3D Printing and Stem Cell Research Advance Treatment for Congenital Heart Disease – 3DPrint.com
Inverse |
3D Printing and Stem Cell Research Advance Treatment for Congenital Heart Disease
3DPrint.com Davis’ research includes extensive work with stem cells. A few years ago, he noticed that during bypass surgery, small amounts of tissue were being removed to run the bypass tubing into the heart, and then discarded. Davis requested and was granted … Human Mini-Kidneys Farmed by Robots Herald the Age of Organ FactoriesInverse Novel robotic system can grow mini human organsDeccan Herald |
Inverse |
3D Printing and Stem Cell Research Advance Treatment for Congenital Heart Disease
3DPrint.com Davis’ research includes extensive work with stem cells. A few years ago, he noticed that during bypass surgery, small amounts of tissue were being removed to run the bypass tubing into the heart, and then discarded. Davis requested and was granted … Human Mini-Kidneys Farmed by Robots Herald the Age of Organ FactoriesInverse Novel robotic system can grow mini human organsDeccan Herald |
3DPrint.com |
3D Printing and Stem Cell Research Advance Treatment for …
3DPrint.com Congenital heart disease is the most common birth defect in the world, affecting almost nine out of every 1000 babies born. Michael Davis, Director of the … CAN SCIENTISTS GROW HUMAN ORGANS IN THE LAB?Daily Mail Mini-Organs Made By Robots Are a ‘Secret Weapon’ in Fighting …Inverse |
|
Fibrocell’s gene therapy FCX-007 shows positive effect in RDEB study; shares up 4%
Seeking Alpha Preliminary data from a Phase 1/2 study evaluating Fibrocell Science’s (FCSC +3.7%) gene therapy, FCX-007, in patients with recessive dystrophic epidermolysis bullosa (RDEB) showed a treatment effect. The data were presented at the International … FIBROCELL SCIENCE, INC. (NASDAQ:FCSC) Files An 8-K Other EventsMarket Exclusive |